Literature DB >> 20098308

Central corneal thickness in mucopolysaccharidosis II and VI.

Ulrike Kottler1, Deniz Demir, Irene Schmidtmann, Michael Beck, Susanne Pitz.   

Abstract

OBJECTIVE: To describe the ultrasonographically detected central corneal thickness (CCT) in patients with Type II and VI mucopolysaccharidosis (MPS) and its impact on applanation tonometry and glaucoma detection.
METHODS: Twenty-eight patients with MPS (19 MPS II, nine MPS VI) underwent pachymetric investigation of CCT. Additionally, ultrasound measurements of axial length of the globe, slit-lamp evaluation with semiquantitative grading of corneal clouding, applanation tonometry, and assessment of refractive error were performed.
RESULTS: Median average corneal thickness was 534.5 microm (range, 491.5-579.0 microm) in the MPS II and 547.0 microm (range, 492.5-693.05 microm) in the MPS VI group. CCT depended on degree of corneal clouding and patients' age, but did not correlate with intraocular pressure, refractive error, axial length, or MPS type. There were no substantial differences in refractive error between MPS II and MPS VI.
CONCLUSION: In our patients, CCT in MPS II and VI did not differ statistically significantly from age-related values found in healthy subjects. Thus, intraocular pressure readings detected by applanation tonometry in MPS II and VI in the majority of patients can be regarded as reliable. In the case of clinically marked corneal clouding, measurement of CCT is recommended to adequately assess intraocular pressure and possible coexistent glaucoma.

Entities:  

Mesh:

Year:  2010        PMID: 20098308     DOI: 10.1097/ICO.0b013e3181b55cc1

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

1.  Anterior segment OCT imaging in mucopolysaccharidoses type I, II, and VI.

Authors:  T Y Ahmed; A M J Turnbull; N F Attridge; S Biswas; I C Lloyd; L Au; J L Ashworth
Journal:  Eye (Lond)       Date:  2014-01-03       Impact factor: 3.775

2.  Intraobserver reliability of contact pachymetry in children.

Authors:  Katherine K Weise; Brett Kaminski; Michele Melia; Michael X Repka; Yasmin S Bradfield; Bradley V Davitt; David A Johnson; Raymond T Kraker; Ruth E Manny; Noelle S Matta; Susan Schloff
Journal:  J AAPOS       Date:  2013-04       Impact factor: 1.220

3.  Spectral domain optical coherence tomography imaging of mucopolysaccharidoses I, II, and VI A.

Authors:  Susie Seok; In Jeong Lyu; Kyung Ah Park; Sei Yeul Oh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-18       Impact factor: 3.117

Review 4.  Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses.

Authors:  Carlton R Fenzl; Kyla Teramoto; Majid Moshirfar
Journal:  Clin Ophthalmol       Date:  2015-09-07

5.  Influence of Corneal Opacity on Intraocular Pressure Assessment in Patients with Lysosomal Storage Diseases.

Authors:  Joanna Wasielica-Poslednik; Giuseppe Politino; Irene Schmidtmann; Katrin Lorenz; Katharina Bell; Norbert Pfeiffer; Susanne Pitz
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

6.  Diagnosis and follow-up of patients with Hunter syndrome in Spain: A Delphi consensus.

Authors:  Luis González-Gutiérrez-Solana; Encarnación Guillén-Navarro; Mireia Del Toro; Jaime Dalmau; Antonio González-Meneses; María L Couce
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

7.  Corneal topometric, aberrometric and biomechanical parameters in mucopolysaccharidosis patients.

Authors:  Joanna Wasielica-Poslednik; Alexander K Schuster; Giuseppe Politino; Susanne Marx-Gross; Katharina Bell; Norbert Pfeiffer; Susanne Pitz
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

Review 8.  Ocular features in mucopolysaccharidosis: diagnosis and treatment.

Authors:  Alessandra Del Longo; Elena Piozzi; Fiammetta Schweizer
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.